Bullboard - Stock Discussion Forum Hemostemix Inc V.HEM

Alternate Symbol(s): HMTXF

Healthcare Biotechnology

Hemostemix Inc. is a Canada-based autologous stem cell therapy company. The Company has developed, patented, and is scaling a patient’s blood-based stem cell therapeutics platform, which includes angiogenic cell precursors, neuronal cell precursors and cardiomyocyte cell precursors. The Company holds 87 patents on the derivation of three stem cell lineages from the patient’s blood, including... see more

Add To Watchlist

TSXV:HEM - Post Discussion

Hemostemix Inc > Hemostemix Announces Partnership and Funding

View:

Post by sdhaka on Jun 04, 2024 2:35pm

Hemostemix Announces Partnership and Funding

Hemostemix Announces Partnership and Funding for ACP-01 Manufacturing

Hemostemix Inc. (HEM) announced a strategic manufacturing partnership with CytoImmune Therapeutics, a private company specializing in clinical manufacturing for biotech firms.

This collaboration involves a Letter of Intent (LOI) to jointly manufacture Hemostemix's lead product, ACP-01. The goal is to provide this investigational treatment to patients with critical needs on a compassionate-use basis.

Compassionate-use programs allow access to unapproved treatments for patients with life-threatening conditions who have no other options.
Read more on this update for free : https://www.researchfrc.com/content/analyst-ideas/post/96/data-backs-our-rate-cut-predictions-time-to-revisit-lithium-stocks

*FRC provides issuer-paid coverage.

*Past performance is not indicative of future results.

101